Group II metabotropic glutamate receptor activation attenuates peripheral sensitization in inflammatory states

J. Du, S. Zhou, S. M. Carlton

    Research output: Contribution to journalArticle

    27 Citations (Scopus)

    Abstract

    Several lines of evidence indicate that Group II metabotropic glutamate receptor (mGluR) activation can depress sensory transmission. We have reported the expression of Group II mGluRs on unmyelinated axons, many of which were presumed to be nociceptors, in the rat digital nerve [Carlton SM, Hargett GL, Coggeshall RE (2001b) Localization of metabotropic glutamate receptors 2/3 on primary afferent axons in the rat. Neuroscience 105:957-969]. The goals of the present study are to further our understanding of Group II modulation of nociceptor processing in the periphery, documenting behavioral changes using inflammatory models and documenting, for the first time, cutaneous single fiber activity following exposure to a Group II agonist (2R,4R)-4-aminopyrrolidine-2,4-dicarboxylate (APDC) and antagonist (2S)-2-amino-2-[(1S,2S)-2-carboxycycloprop-1-yl]-3-(xanth-9-yl) propanoic acid (LY341495, LY). The data indicate that peripheral Group II mGluR activation does not depress nociceptive behaviors or nociceptor fiber responses in the non-sensitized state (i.e. following brief nociceptive mechanical or thermal stimulation) but can depress these responses when nociceptors are sensitized by exposure to formalin or inflammatory soup. Group II mGluR agonist-induced inhibition can be blocked by a selective Group II antagonist. Peripheral Group II mGluR-induced inhibition evoked in these studies occurs through activation of local receptors and not through spinal or supraspinal mechanisms. The data indicate that administration of selective Group II agonists may be potent therapeutic agents for prevention of peripheral sensitization and for treatment of inflammatory pain.

    Original languageEnglish (US)
    Pages (from-to)754-766
    Number of pages13
    JournalNeuroscience
    Volume154
    Issue number2
    DOIs
    StatePublished - Jun 23 2008

    Fingerprint

    Nociceptors
    Metabotropic Glutamate Receptors
    Axons
    LY 341495
    Excitatory Amino Acid Agonists
    Neurosciences
    Formaldehyde
    Hot Temperature
    Pain
    Skin
    Therapeutics
    Inhibition (Psychology)

    Keywords

    • APDC
    • formalin
    • Group II mGluR
    • inflammation
    • LY341495
    • pain

    ASJC Scopus subject areas

    • Neuroscience(all)

    Cite this

    Group II metabotropic glutamate receptor activation attenuates peripheral sensitization in inflammatory states. / Du, J.; Zhou, S.; Carlton, S. M.

    In: Neuroscience, Vol. 154, No. 2, 23.06.2008, p. 754-766.

    Research output: Contribution to journalArticle

    @article{48c86824bcfd4055b2a9175ef664a51f,
    title = "Group II metabotropic glutamate receptor activation attenuates peripheral sensitization in inflammatory states",
    abstract = "Several lines of evidence indicate that Group II metabotropic glutamate receptor (mGluR) activation can depress sensory transmission. We have reported the expression of Group II mGluRs on unmyelinated axons, many of which were presumed to be nociceptors, in the rat digital nerve [Carlton SM, Hargett GL, Coggeshall RE (2001b) Localization of metabotropic glutamate receptors 2/3 on primary afferent axons in the rat. Neuroscience 105:957-969]. The goals of the present study are to further our understanding of Group II modulation of nociceptor processing in the periphery, documenting behavioral changes using inflammatory models and documenting, for the first time, cutaneous single fiber activity following exposure to a Group II agonist (2R,4R)-4-aminopyrrolidine-2,4-dicarboxylate (APDC) and antagonist (2S)-2-amino-2-[(1S,2S)-2-carboxycycloprop-1-yl]-3-(xanth-9-yl) propanoic acid (LY341495, LY). The data indicate that peripheral Group II mGluR activation does not depress nociceptive behaviors or nociceptor fiber responses in the non-sensitized state (i.e. following brief nociceptive mechanical or thermal stimulation) but can depress these responses when nociceptors are sensitized by exposure to formalin or inflammatory soup. Group II mGluR agonist-induced inhibition can be blocked by a selective Group II antagonist. Peripheral Group II mGluR-induced inhibition evoked in these studies occurs through activation of local receptors and not through spinal or supraspinal mechanisms. The data indicate that administration of selective Group II agonists may be potent therapeutic agents for prevention of peripheral sensitization and for treatment of inflammatory pain.",
    keywords = "APDC, formalin, Group II mGluR, inflammation, LY341495, pain",
    author = "J. Du and S. Zhou and Carlton, {S. M.}",
    year = "2008",
    month = "6",
    day = "23",
    doi = "10.1016/j.neuroscience.2008.03.084",
    language = "English (US)",
    volume = "154",
    pages = "754--766",
    journal = "Neuroscience",
    issn = "0306-4522",
    publisher = "Elsevier Limited",
    number = "2",

    }

    TY - JOUR

    T1 - Group II metabotropic glutamate receptor activation attenuates peripheral sensitization in inflammatory states

    AU - Du, J.

    AU - Zhou, S.

    AU - Carlton, S. M.

    PY - 2008/6/23

    Y1 - 2008/6/23

    N2 - Several lines of evidence indicate that Group II metabotropic glutamate receptor (mGluR) activation can depress sensory transmission. We have reported the expression of Group II mGluRs on unmyelinated axons, many of which were presumed to be nociceptors, in the rat digital nerve [Carlton SM, Hargett GL, Coggeshall RE (2001b) Localization of metabotropic glutamate receptors 2/3 on primary afferent axons in the rat. Neuroscience 105:957-969]. The goals of the present study are to further our understanding of Group II modulation of nociceptor processing in the periphery, documenting behavioral changes using inflammatory models and documenting, for the first time, cutaneous single fiber activity following exposure to a Group II agonist (2R,4R)-4-aminopyrrolidine-2,4-dicarboxylate (APDC) and antagonist (2S)-2-amino-2-[(1S,2S)-2-carboxycycloprop-1-yl]-3-(xanth-9-yl) propanoic acid (LY341495, LY). The data indicate that peripheral Group II mGluR activation does not depress nociceptive behaviors or nociceptor fiber responses in the non-sensitized state (i.e. following brief nociceptive mechanical or thermal stimulation) but can depress these responses when nociceptors are sensitized by exposure to formalin or inflammatory soup. Group II mGluR agonist-induced inhibition can be blocked by a selective Group II antagonist. Peripheral Group II mGluR-induced inhibition evoked in these studies occurs through activation of local receptors and not through spinal or supraspinal mechanisms. The data indicate that administration of selective Group II agonists may be potent therapeutic agents for prevention of peripheral sensitization and for treatment of inflammatory pain.

    AB - Several lines of evidence indicate that Group II metabotropic glutamate receptor (mGluR) activation can depress sensory transmission. We have reported the expression of Group II mGluRs on unmyelinated axons, many of which were presumed to be nociceptors, in the rat digital nerve [Carlton SM, Hargett GL, Coggeshall RE (2001b) Localization of metabotropic glutamate receptors 2/3 on primary afferent axons in the rat. Neuroscience 105:957-969]. The goals of the present study are to further our understanding of Group II modulation of nociceptor processing in the periphery, documenting behavioral changes using inflammatory models and documenting, for the first time, cutaneous single fiber activity following exposure to a Group II agonist (2R,4R)-4-aminopyrrolidine-2,4-dicarboxylate (APDC) and antagonist (2S)-2-amino-2-[(1S,2S)-2-carboxycycloprop-1-yl]-3-(xanth-9-yl) propanoic acid (LY341495, LY). The data indicate that peripheral Group II mGluR activation does not depress nociceptive behaviors or nociceptor fiber responses in the non-sensitized state (i.e. following brief nociceptive mechanical or thermal stimulation) but can depress these responses when nociceptors are sensitized by exposure to formalin or inflammatory soup. Group II mGluR agonist-induced inhibition can be blocked by a selective Group II antagonist. Peripheral Group II mGluR-induced inhibition evoked in these studies occurs through activation of local receptors and not through spinal or supraspinal mechanisms. The data indicate that administration of selective Group II agonists may be potent therapeutic agents for prevention of peripheral sensitization and for treatment of inflammatory pain.

    KW - APDC

    KW - formalin

    KW - Group II mGluR

    KW - inflammation

    KW - LY341495

    KW - pain

    UR - http://www.scopus.com/inward/record.url?scp=46549089146&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=46549089146&partnerID=8YFLogxK

    U2 - 10.1016/j.neuroscience.2008.03.084

    DO - 10.1016/j.neuroscience.2008.03.084

    M3 - Article

    VL - 154

    SP - 754

    EP - 766

    JO - Neuroscience

    JF - Neuroscience

    SN - 0306-4522

    IS - 2

    ER -